Literature DB >> 12481730

Computed tomography and magnetic resonance imaging evaluation of liver cancer.

Mukesh G Harisinghani1, Peter F Hahn.   

Abstract

Focal liver lesions occur commonly and with varying histology, each requiring radically different management. There are a multitude of imaging modalities currently being used for detecting and characterizing focal liver neoplasms. The primary modalities include ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and rarely, angiography. CT and MRI have benefited from rapid technologic advances, and MRI, in particular, from the advent of new contrast agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481730     DOI: 10.1016/s0889-8553(02)00028-6

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  5 in total

1.  Liver fibrosis in chronic viral hepatitis: an ultrasonographic study.

Authors:  Rong-Qin Zheng; Qing-Hui Wang; Ming-De Lu; Shi-Bin Xie; Jie Ren; Zhong-Zhen Su; Yin-Ke Cai; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

2.  A practical approach to managing patients with HCV infection.

Authors:  Richard H Huang; Ke-Qin Hu
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

3.  Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.

Authors:  Hossein Ghanaati; Seyed Moayed Alavian; Ali Jafarian; Nasser Ebrahimi Daryani; Mohsen Nassiri-Toosi; Amir Hossein Jalali; Madjid Shakiba
Journal:  Iran J Radiol       Date:  2012-11-20       Impact factor: 0.212

4.  Liver cancer imaging: role of CT, MRI, US and PET.

Authors:  Maria Raquel Oliva; Sanjay Saini
Journal:  Cancer Imaging       Date:  2004-04-02       Impact factor: 3.909

5.  Atypical mycobacterial infection mimicking metastatic cholangiocarcinoma.

Authors:  Harsh A Kanhere; Markus I Trochsler; John Pierides; Guy J Maddern
Journal:  J Surg Case Rep       Date:  2013-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.